Category Science and Technology
The Privacy Paradox and Duty to Warn
Kathy Hodgkinson and Daryl Pullman propose that high risk/high recurrence genetic diseases should come under the purview of public health.
First CRISPR Babies: Where are our Ethics?
Françoise Baylis responds to the recently announced birth of the world’s first genome edited babies and raises concerns about the scientific practice and ethical accountability.
Monopolies on New Medicines & Trade with the U.S.
Deborah Gleeson and Ronald Labonté object to lengthening market exclusivity for biologic medicines in the United States-Mexico-Canada Agreement.
From Bench to Bedside via… The Island of Dr Moreau?
Jason Scott Robert suggests that the creation of part-human animals in stem cell biology may generate scientific confusion.
Join the Debate on Human Genome Editing!
Yeyang Su invites Impact Ethics readers to mark their calendars for the second International Summit on Human Genome Editing.
Pharmacare: Improving Access to Expensive Drugs
Marc-André Gagnon dispels misconceptions about the benefits of private health insurance plans and argues in favour of a universal model for pharmacare.
The Privacy Implications of Human DNA Sequencing
Landon J. Getz explores the privacy minefield of commercial DNA Sequencing, and how it has become relevant in recent news.
